US67080N1019
US67080N1019
Nuvation Bio Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.76B EUR | 1.99B EUR | 1.49B EUR | 3.1B EUR |
Enterprise Value | 1.49B EUR | 1.98B EUR | 1.42B EUR | 3B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -333.33x | -- | -- | -- |
Price to Sales | 10.33x | 11.7x | 10.43x | 51.9x |
Price to Book | 6.89x | 7.83x | 4.67x | 10.16x |
EV/Revenue | 8.79x | 11.66x | 9.95x | 50.12x |
EV/EBITDA | -11.02x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -6.39% | -6.49% | -8.99% | -4.48% |